FIELD: medicine, pharmacology.
SUBSTANCE: the present innovation deals with applying pharmaceutical composition as an antagonist of NPY Y5 receptor that contains the compound of formula I
, moreover, it deals with compounds of formula I and method for treating obesity and suppressing food intake, as well.
EFFECT: higher efficiency of therapy.
18 cl, 13 ex, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 5-MEMBERED HETEROCYCLIC COMPOUND AND ITS APPLICATION FOR MEDICINAL PURPOSES | 2008 |
|
RU2515968C2 |
| WATER-SOLUBLE PHENYLPYRIDAZINE DERIVATIVES AND THERAPEUTICAL AGENTS CONTAINING THEM | 2002 |
|
RU2302413C2 |
| HERBICIDES FOR WEEDS RESISTANT TO SULFONYLUREA-BASE HERBICIDE, METHOD FOR CONTROL OF WEEDS RESISTANT TO SULFONYLUREA-BASE HERBICIDE, COMPOUNDS | 2003 |
|
RU2292139C2 |
| DERIVATIVES OF TETRAHYDROISOQUINOLINE AND THEIR SALTS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2256661C2 |
| AGONISTS OF RECEPTOR OF PEPTIDE-1, SIMILAR TO GLUCAGONE, THEIR OBTAINING AND APPLICATION | 2003 |
|
RU2342368C2 |
| DIHYDRONAPHTHALENE DERIVATIVES AND MEDICINAL AGENT COMPRISING INDICATED DERIVATIVES AS ACTIVE COMPONENT | 2001 |
|
RU2268262C2 |
| COMPOUNDS OF N,N-SUBSTITUTED CYCLIC AMINE | 1999 |
|
RU2232156C2 |
| NEW CATECHIN DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING CATECHIN DERIVATIVE, USING CATECHIN DERIVATIVE AND USING PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2459812C2 |
| PYRIMIDINE-2,4-DIAMINE DERIVATIVES FOR CANCER TREATMENT | 2013 |
|
RU2672916C2 |
| HIGHLY ACTIVE METATHESIS CATALYSTS SELECTIVE FOR ROMP AND RCM REACTIONS | 2010 |
|
RU2546656C2 |
